Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond Dittamore V currently holds 105,597 shares of OBALON THERAPEUTICS INC (OBLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond Dittamore V has been a net seller of OBLN stock. They have purchased $0 and sold $11.0M worth of shares.
Raymond Dittamore V's most recent insider trade was on Jul 23, 2019, when they sold 78,125 shares at $0.00 per share.
Raymond Dittamore V serves as Executive at OBALON THERAPEUTICS INC (OBLN). They have executed 90 insider transactions totaling $11.0M over their tenure at the company.
Raymond Dittamore V holds the position of Executive at OBALON THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Raymond Dittamore V has shown a selling trading pattern, with $0 in total purchases and $11.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Raymond Dittamore V was on Feb 3, 2014, when they sold $1.8M worth of LIFE shares. This transaction involved 23,073 shares at $76.13 per share.
Raymond Dittamore V currently owns 105,597 shares of OBALON THERAPEUTICS INC (OBLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond Dittamore V's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond Dittamore V has 90 Form 4 filings on record as an insider at OBALON THERAPEUTICS INC.
Set alerts for Raymond Dittamore V and 40,000+ other insiders.